820232-50-6
820232-50-6 structure
- Name: Pasireotide diaspartate
- Chemical Name: Pasireotide diaspartate
- CAS Number: 820232-50-6
- Molecular Formula: C66H80N12O17
- Molecular Weight: 1313.412
- Create Date: 2021-01-08 09:53:04
- Modify Date: 2024-01-09 12:07:58
-
Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
| Name | Pasireotide diaspartate |
|---|---|
| Synonyms |
I4P76SY3N4
L-Aspartic acid, compd. with cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl] (2:1) pasireotide aspartate Pasireotide diaspartate L-Aspartic acid - cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl] (2:1) Signifor |
| Molecular Formula | C66H80N12O17 |
|---|---|
| Molecular Weight | 1313.412 |
| Exact Mass | 1312.576416 |